Fierce Pharma Asia—Trump's investment policy; Pfizer's tariff mitigation plan; CMIC's stake sale
U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments related to China in several sectors, including biotech. Pfizer could shift overseas production to the U.S. if tariffs become a problem, CEO Albert Bourla said. Blackstone bought a 60% stake in Japanese CRO giant CMIC. And more.
U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments related to China in several sectors, including biotech. Pfizer could shift overseas production to the U.S. if tariffs become a problem, CEO Albert Bourla said. Blackstone bought a 60% stake in Japanese CRO giant CMIC. And more.
